{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:19:04Z","timestamp":1767676744578,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.arcmed.2013.10.012","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T15:15:26Z","timestamp":1386429326000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Plasma Level of Glucagon-like Peptide 1 in Obese Egyptians with Normal and Impaired Glucose Tolerance"],"prefix":"10.1016","volume":"45","author":[{"given":"Magda S.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal M.","family":"Abushady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Refaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2013.10.012_bib1","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.285.16.2109","article-title":"Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study","volume":"285","author":"De Vegt","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2013.10.012_bib2","first-page":"1","article-title":"Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose","volume":"128","author":"Santaguida","year":"2006","journal-title":"AHRQ Study"},{"key":"10.1016\/j.arcmed.2013.10.012_bib3","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1210\/endo.142.10.8430","article-title":"Oxyntomodulin inhibits food intake in the rat","volume":"142","author":"Dakin","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2013.10.012_bib4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide-1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.arcmed.2013.10.012_bib5","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/diacare.24.9.1640","article-title":"Impaired incretin response after a mixed meal is associated with insulin resistance in non-diabetic men","volume":"24","author":"Rask","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2013.10.012_bib6","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsboll","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2013.10.012_bib7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/sj.ijo.0801655","article-title":"The role of postprandial releases of insulin and incretin hormones in meal-induced satiety\u2013effect of obesity and weight reduction","volume":"25","author":"Verdich","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.arcmed.2013.10.012_bib8","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jcem.86.8.7743","article-title":"Determinants of the effectiveness of Glucagon-like peptide 1 in type 2 diabetes","volume":"86","author":"Toft-Nielsen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2013.10.012_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.K09E-269","article-title":"Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes","volume":"7","author":"Lee","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.arcmed.2013.10.012_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-010-1896-4","article-title":"Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?","volume":"54","author":"Nauck","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2013.10.012_bib11","unstructured":"World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva;\u00a02004."},{"key":"10.1016\/j.arcmed.2013.10.012_bib12","first-page":"543","article-title":"American Diabetes Association: Diagnosis and classification of Diabetes mellitus","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2013.10.012_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/000456326900600108","article-title":"Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor","volume":"6","author":"Trinder","year":"1969","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.arcmed.2013.10.012_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2013.10.012_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabetes Med"},{"key":"10.1016\/j.arcmed.2013.10.012_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-1759(92)90061-W","article-title":"Enzyme immunoassay techniques, an overview","volume":"150","author":"Porstmann","year":"1992","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.arcmed.2013.10.012_bib17","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","article-title":"Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients","volume":"57","author":"Muscelli","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2013.10.012_bib18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2337\/db07-1124","article-title":"Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance","volume":"57","author":"Vollmer","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.arcmed.2013.10.012_bib19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7150\/ijms.4128","article-title":"Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance","volume":"9","author":"Fang","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.arcmed.2013.10.012_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.ijo.0802561","article-title":"Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults","volume":"28","author":"Velasquez-Mieyer","year":"2004","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440913002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440913002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:41:36Z","timestamp":1759261296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440913002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0188440913002579"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2013.10.012","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Level of Glucagon-like Peptide 1 in Obese Egyptians with Normal and Impaired Glucose Tolerance","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2013.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}